Showing results (1331-1340 of 3,083) with videos related to

Sort By:
Pageof 309
Drug Safety|January 17, 2019
Safety and Tolerability of Immune Checkpoint Inhibitors (PD-1 and PD-L1) in CancerIosune Baraibar, Ignacio Melero, Mariano Ponz-Sarvise, et al.
Drug Safety|January 17, 2019
Benefit-Risk Assessment of Plecanatide in the Treatment of Chronic Idiopathic ConstipationPhilip B Miner
Drug Safety|January 17, 2019
Safety and Tolerability of Phosphatidylinositol-3-Kinase (PI3K) Inhibitors in OncologyGiuseppe Curigliano, Rashmi R Shah
Drug Safety|January 17, 2019
Evaluation of Antibody Properties and Clinically Relevant Immunogenicity, Anaphylaxis, and Hypersensitivity Reactions in Two Phase III Trials of Tralokinumab in Severe, Uncontrolled AsthmaMats Carlsson, Martin Braddock, Yuling Li, et al.
Drug Safety|September 25, 2020
Community Pharmacists' Views and Experiences with ADR Reporting for Complementary Medicines: A Qualitative Study in New ZealandJoanne Barnes, Rachael Butler
Drug Safety|September 29, 2020
Patient Organizations' Barriers in Pharmacovigilance and Strategies to Stimulate Their ParticipationKatherine Chinchilla, Cristiano Matos, Victoria Hall, et al.
Drug Safety|January 14, 2020
Cardiac Safety of the Trastuzumab Biosimilar ABP 980 in Women with HER2-Positive Early Breast Cancer in the Randomized, Double-Blind, Active-Controlled LILAC StudyHans-Christian Kolberg, Marco Colleoni, Georgia Savva Demetriou, et al.
Drug Safety|October 24, 2020
Chances and Challenges of Registry-Based Pharmacovigilance in Multiple Sclerosis: Lessons Learnt from the Implementation of the Multicenter REGIMS RegistryAlexandra Simbrich, Jasmine Thibaut, Laura Khil, et al.
Drug Safety|September 30, 2020
Assessing the Safety of COVID-19 Vaccines: A PrimerHelen Petousis-Harris
Drug Safety|April 3, 2020
Enhancing Pharmacovigilance in Sub-Saharan Africa Through Training and Mentoring: A GSK Pilot Initiative in MalawiViviane Jusot, Frider Chimimba, Nettie Dzabala, et al.
Pageof 309